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C 4.5 Immediate Postprocedural Issues
C 4.5.1 Reperfusion Injury
Reperfusion injury is one of the most common complications leading to prolonged morbidity.
The sudden return of oxygenated blood to acutely ischemic muscle causes the generation and
release of oxygen free radicals and subsequent cellular injury. Failure to anticipate or recognize
this complication can lead to the rapid development of compartment syndrome and myonecrosis.
Treatment consists of fasciotomy. Prevention of reperfusion injury is the focus of much experi-
mental research, but effective drug regimens have not been established for clinicalpractice.
Other long-term complications include the persistence of sensory or motor impairment. Loss of
sensation in the toes and foot increases the likelihood ofdevelopment of neurotrophic ulceration.
Such ulcers are more common in the setting of impaired motor function, A polyneuropathy is
the most common form of residual nerve impairment, although selective damage to individual
nerves has been reported. The manifestations of nerve damage include wasting of the small mus-
cles of the foot associated with painful dysesthesias, leading to an alteration in gait. Treatment
consists of attempts at pharmacological control of pain, bracing of the foot, and physicaltherapy
until neuromotor function improves. This may require many months of intensive therapy.
C 4.5.2 Fasciotomy
Although fasciotomy in every case would produce unacceptable and unnecessary morbidity, in
practice it is often left too late. Compartment pressure measures have been employed to some
advantage, but there is disagreement on pressure criteria for proceeding with fasciotomy. After
revascularization, fasciotomy also should be performed if there are signs of increased ischemia
without evidence of reocclusion. A long skin incision and opening of all compartments, includ-
ing the deep posterior compartment, are needed unless initial inspection shows no muscle death
or swelling.
Recommendation 62: FasciotQrny in acute limb ischemia
Fasciotomy should be performed at the primary procedure if the acute severe ischemia
has been prolonged or if signs of increased compartment pressure develop. This applies
irrespective of how the clot was removed.
C4.6
Critical Issue 24: Predicting the requirement for fasciotomy
There is a need for an easy and accurate test to predict which patients require a fasciotomy.
Treatment of the Underlying Lesion
Simply removing the occluding lesion, whether it is a thrombus or an embolus, is unlikely to be
successful as the sale treatment. If the occlusion was caused by all embolus, the source has to be
identified and treated. If the acute occlusion was caused by thrombosis superimposed on preex-
isting atherosclerosis, then this underlying lesion also has to be treated to avoid a recurrence of
the acute occlusion. This may be accomplished by either an endovascular or and open surgical
technique, depending on the balance between durable success and procedural risk. The results
of PTA in the literature are dependent on morphology of the lesion and patient selection and
the criteria used to define technical and clinical success and patency. These are well discussed in
sections B 4.3, Endovascular Procedures for Intermittent Claudication (p 597), D 4.6,
Aortoiliac Discase-Endovascular Treatment (p 5214), D 4.9, Infrainguinal Lesions-
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Endovascular Treatment (p S226). In general, the choice of treatment of the underlying
lesion(s) should follow the same principles outlined in section D . Thus, the choice of treatment
of an underlying lesion that caused the clot should be separated from the choice of method of
clot removal. That is, thrombolysis should not lead to PTA of extensive atherosclerotic disease,
which is better treated by surgery. Similarly, thrombectomy should not lead to bypass of a dis-
crete underlying stenosis, which is amenable to PTA.
Recommendation 63: Treatment of underlying lesion(s) in acute limb ischemia
It is important to identify the underlying cause of the acute limb ischemia, for instance,
the source of emboli. Ideally this should be done before intervention.
Recommendation 64: Choice of treatment of underlying lesion(s)
After relief of acute limb ischemia and establishing its etiology, the choice of treatment
of the underlying lesion should be similar to the choice of treatment in the setting of
chronic limb ischemia and not automatically linked to the method of clot removal.
Management of Graft Thrombosis
When considering late graft thrombosis, the main goals are to remove the clot and correct the
underlying lesion that caused the thrombosis. Alteration in the inflow and outflow arteries is
usually caused by the progression of atherosclerosis and should be treated with either PTA or
bypass grafting, as detailed elsewhere. Lesions intrinsic to the graft are dependent on the type of
conduit. Venous bypass grafts may develop stenoses, typically at the site of a valve.! After
thrombolysis and identification of the lesion, it may be treated with either PTA or surgical revi-
sion, the latter usually being favored for its superior long-term results .s Prosthetic grafts develop
intimal hyperplasia, typically at the distal anastomosis. These rubbery lesions respond differently
to PTA than do the typical eccentric atherosclerotic plaque and do not yield as durable results.
This has led many surgeons to suggest that treatment should be exposure of the involved anas-
tomosis, with graft thrombectomy and patch angioplasty of the narrowed graft/artery anasto-
mosis or a simple extension graft.
Follow-up Care
All patients should be heparinized in the immediate postoperative period. Roughly half of post-
operative deaths are caused by thromboembolic complications, so patients should receive antico-
agulant drugs from the time of operation. This should initially be with heparin (20,000-40,000
IV/day) for 1 week, followed by warfarin for at least 3 months.f Green et al4 found a 31% in-
hospital recurrence of embolism in those not receiving coumarin derivatives versus 9% in those
who did receive anticoagulant. It should, however, be mentioned that a more recent randomized
study failed to show any improvement in I-month results with anticoagulation.s
Whether to continue coumarin drugs longer term is controversial. Elliott er al ,6 in a long-term
follow-up of the Henry Ford Hospital experience, showed that long-term anticoagulation
resulted in a lower embolism recurrence rate and a better survival . As might be expected,
embolism series are likely to show a benefit to long-term anticoagulant therapy, whereas studies
in which cases of arterial thrombosis predominate may not. Long-term anticoagulation is there-
fore recommended for cases of arterial embolism, whenever the source has been neither effec-
tively controlled nor identified. The source of an embolus should be investigated, for instance,
by echocardiography, although often the cause remains obscure. Long-term anticoagulation
should be considered in arterial thrombosis when, even after treatment, the risk of rethrombosis
is still significant based on the remaining arterial lesions. Atrial fibrillation causing arterial
embolism requires long-term anticoagulation. Long-term anticoagulation in these cases usually
means lifelong, but it should be assessed individually in light of the patient's coexisting disease.
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Critical Issue 25: Long-term anticoagulation after thromboembolectomy
There is a need for further information to determine whether long-term anticoagulation is
useful after successful thromboembolectomy in the absence of a proven source of emboli.
Management of a Thrombosed Popliteal Aneurysm
Thrombolysis alone is insufficient in these cases because it is unlikely to completely clear the
thrombus from the aneurysm. More importantly, the thrombosis will recur . Exclusion of the
aneurysm with a surgical bypass may be sufficient alone, in the few cases in which there has
been no extension of the thrombus or embolization into the run-off vessels. Thrombolysis has
to be used to reestablish the patency of the run-off vessels followed as soon as possible by a
bypass procedure. Reversed vein is a conduit of choice. If the patient has a significant popliteal
aneurysm on the other side (large or thrombus-lined), then this should be treated electively by
surgery, because the final results are far superior to treating thrombosed aneurysms."
Recommendation 65: Treatment of thrombosed popliteal aneurysm
In thrombosed popliteal aneurysms causing acute limb ischemia with poor infrapopliteal
runoff, initial treatment by intraarterial thrombolysis or distal thrombectomy is indicat-
ed, followed by exclusion of the aneurysm by a surgical bypass procedure.
C 4.10 Primary Amputation
Primary amputation is preferred for patients with prolonged irreversible ischemia or if, in the
judgment of the clinician, revascularization of the severely ischemic limb could jeopardize the
patient's life (see Figure 17 and D 4.17, Amputation, p 5267).8
C 4.11 Management Algorithm
The management scheme proposed in Figure 24 is based on (1) the severity of the acute limb
ischemia at the time of presentation, determined by clinical evaluation and Doppler study, as
developed above into a clinical classification; (2) the reality that the time and place for angiogra-
phy and the choice of the method of clot removal will most often be determined by time con-
straints related to the degree of urgency for revascularization-that is, the severity of ischemia.
Additional considerations are (3) essentially all patients need early heparin administration to
avoid clot propagation; (4) the choice of treatment of any underlying lesion after clot removal
should depend on the morphology of the lesion itself and should be independent of the method
of clot removal . It should be pointed out that although this algorithm may apply under ideal cir-
cumstances, paths in this decision tree may be blocked by existing local conditions, for example,
the unavailability of catheter-directed thrombolytic therapy or of an open operating room. All
patients receive heparin early, as soon as it is determined by clinical examination and differential
diagnosis that me problem is acute arterial thromboembolism. The patients are then categorized
on the basis of clinical examination and Doppler study into one of four previous described clini-
cal categories, tl1US stratifying them according to severity of ischemia.
Class I patients, that is, with a clearly viable leg, should have formal angiography if they are
decided to ultimately require revascularization. Revascularization may be delayed until a more
complete evaluation is accomplished. In fact, although it might be convenient and cost-saving to
proceed with therapy during the same admission, the same careful deliberation should be used
in such patients as with critical limb ischemia . One of me reasons mat me results of thrombolyt-
ic therapy are significantly better within 2 weeks of the occlusion.
Class IIA, marginally threatened patients, should also be sent for formal angiography in the
angiographic suite. This should be done promptly and with the patient under close surveillance
in case of deterioration. Both class I and IIA patients should undergo catheter-directed lytic
therapy at the time of arteriography. Further treatment would depend on the ability to gain
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Figure 24: Ideal Management Algorithm for the Treatment ofAcute Limb Ischemia.
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access, the success of that therapy, and the lesion uncovered (eg, nothing but anticoagulation,
PTA, bypass). Class lIB, immediately threatened, patients should be taken promptly to the oper-
ating theater to undergo surgical thromboembolectomy, The adequacy of this procedure should
be controlled by intraoperative angiography. Depending on the completeness of clot removal,
adjunctive lytic therapy may be given by instillation or infusion, Again, further therapy would
depend on the nature of the underlying lesion (eg, anticoagulation alone, PTA, bypass).
Fasciotomy may well be required in this group (see earlier discussion in this section).
Class III patients are those with irreversible changes that preclude salvage of a functional foot.
These should remain anticoagulated but undergo amputation once the level of amputation is
apparent, although systemic metabolic complications of ischemic skeletal muscle may, in some
circumstances, require early amputation. Most of these patients not only have profound
ischemia but will have presented after significant delay. Attempted revascularization of such
patients is not only fruitless but may be life threatening. This is because of the reperfusion syn-
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drome, with metabolic complications (acidosis, hyperkalemia), renal failure secondary to myo-
globinuria, pulmonary embolism, or cardiac failure or arrhythmias. However, those with early
profound ischemia should have attempted thromboembolectomy, because the distinction
between class lIA and class III is difficult to make in the early hours after acute arterial occlu-
sion.
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C 5 Economic Aspects of Acute Limb Ischemia
Compared with the management of critical limb ischemia, the investigations and treatments of
ALI have been subjected to very few economic analyses, possibly because of the urgency and
the limited number of therapeutic options. The economic data on amputation is presented in
Economic Aspects of Critical Limb Ischemia, D 5, P S274.
The health care costs of treating an occlusion in an isolated native peripheral artery were esti-
mated by Janosik et all and Ourielet al,2 from several retrospective series of patients treated with
either thrombolytic therapy, with urokinase or streptokinase, or surgical thrombectomy. Only
the costs of the initial admission were included, and hospital charges were used as a proxy for
costs. Comorbid conditions were not documented. The most striking results are the conver-
gence of economic data calculated between 1990 and 1993 that show similar mean charges.
These range from $20,000 (EUR 18,600) to $26,000 (EUR24,180) for all three treatments.
Patients treated with urokinase have shorter length of stay but higher drug charges. However,
the relevance of the comparison is limited by the fact that these were retrospective studies.
Thus, it appears that when considering different strategies for thrombectomy, cost is not a deci-
sion criterion.f A similar figure of $25,000 (EUR 23,250) for thromboembolectomy wasfound
by Hoch et a1 4 in 1994, who reported higher costs of$45,000 (EUR41,850) and worse
results when urokinase was used as well in the procedure. Lower costs of surgical revasculariza-
tion were found by Singh et al in a 1993 to 1995 study in the United Kingdom. Their $6,617
(EUR 6,154) cost per patient included the cost of the initial procedure and a 12-month follow-
up.f This study did not compare sw-gery with other treatments,
Thus, the choice between surgery and thrombolysis for ALI should not be based on economic
factors but rather on predicted best clinical outocme. This is because both treatments have simi-
lar hospital costs in one study, whereas surgery is the better option in terms of results and lower
costs from another study. (See Results of Surgical and Endovascular Procedures for Acute Limb
Ischemia, C 4.4, P 5155, for analysis of the conflicting data comparing catheter-directed throm-
bolysis and surgery for ALI.)
